The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model.

While the infection rate of orthopedic implants is low, the required treatment, which can involve six weeks of antibiotic therapy and two additional surgical operations, is life threatening and expensive, and thus motivates the development of a one-stage re-implantation procedure. Polyelectrolyte multilayers incorporating gentamicin were fabricated using the layer-by-layer deposition process for use as a device coating to address an existing bone infection in a direct implant exchange operation. The films eluted about 70% of their payload in vitro during the first three days and subsequently continued to release drug for more than four additional weeks, reaching a total average release of over 550 microg/cm(2). The coatings were demonstrated to be bactericidal against Staphylococcus aureus, and degradation products were generally nontoxic towards MC3T3-E1 murine preosteoblasts. Film-coated titanium implants were compared to uncoated implants in an in vivo S. aureus bone infection model. After a direct exchange procedure, the antimicrobial-coated devices yielded bone homogenates with a significantly lower degree of infection than uncoated devices at both day four (p < 0.004) and day seven (p < 0.03). This study has demonstrated that a self-assembled ultrathin film coating is capable of effectively treating an experimental bone infection in vivo and lays the foundation for development of a multi-therapeutic film for optimized, synergistic treatment of pain, infection, and osteomyelitis.

[1]  G. Lewis,et al.  Estimation of the optimum loading of an antibiotic powder in an acrylic bone cement: Gentamicin sulfate in SmartSet HV , 2006, Acta orthopaedica.

[2]  D. M. Lynn,et al.  Controlling interlayer diffusion to achieve sustained, multiagent delivery from layer-by-layer thin films , 2006, Proceedings of the National Academy of Sciences.

[3]  T. He,et al.  Layer-by-layer assembly to modify poly(l-lactic acid) surface toward improving its cytocompatibility to human endothelial cells. , 2003, Biomacromolecules.

[4]  M. Vallet‐Regí,et al.  Biocompatibility and in vivo gentamicin release from bioactive sol-gel glass implants. , 2002, Journal of biomedical materials research.

[5]  R. Darouiche,et al.  In vivo efficacy of antimicrobial-coated devices. , 2007, The Journal of bone and joint surgery. American volume.

[6]  Robert Langer,et al.  Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA , 2000 .

[7]  N. Haas,et al.  Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. , 2003, Bone.

[8]  J. Chluba,et al.  3-D surface charges modulate protrusive and contractile contacts of chondrosarcoma cells. , 2003, Cell motility and the cytoskeleton.

[9]  P. Stewart,et al.  Theoretical aspects of antibiotic diffusion into microbial biofilms , 1996, Antimicrobial agents and chemotherapy.

[10]  P. Leggat,et al.  Toxicity of methyl methacrylate in dentistry. , 2003, International Dental Journal.

[11]  R. Elson,et al.  Antibiotic-loaded acrylic cement: current concepts. , 1984, Clinical orthopaedics and related research.

[12]  Meital Zilberman,et al.  Gentamicin-loaded bioresorbable films for prevention of bacterial infections associated with orthopedic implants. , 2007, Journal of biomedical materials research. Part A.

[13]  J. Schlenoff,et al.  Factors Controlling the Growth of Polyelectrolyte Multilayers , 1999 .

[14]  P. Schaaf,et al.  From exponential to linear growth in polyelectrolyte multilayers. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[15]  D. M. Lynn,et al.  Construction of hydrolytically-degradable thin films via layer-by-layer deposition of degradable polyelectrolytes. , 2002, Journal of the American Chemical Society.

[16]  Yaron S Brin,et al.  Gentamicin extended release from an injectable polymeric implant. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[17]  S. Datta,et al.  Drug-eluting implants for osteomyelitis. , 2007, Critical reviews in therapeutic drug carrier systems.

[18]  Gero Decher,et al.  Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites , 1997 .

[19]  K. Klemm.  The use of antibiotic-containing bead chains in the treatment of chronic bone infections. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  N. Cioffi,et al.  Analytical investigations of poly(acrylic acid) coatings electrodeposited on titanium-based implants: a versatile approach to biocompatibility enhancement , 2007, Analytical and bioanalytical chemistry.

[21]  S. Dubas,et al.  Mechanism of Polyelectrolyte Multilayer Growth: Charge Overcompensation and Distribution , 2001 .

[22]  J. Rosenblatt,et al.  The Effect of Electrostatic Charge Interactions on Release Rates of Gentamicin from Collagen Matrices , 1995, Pharmaceutical Research.

[23]  J. Andrews,et al.  Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.

[24]  G. Koenig,et al.  VEGF‐Functionalized Polyelectrolyte Multilayers as Proangiogenic Prosthetic Coatings , 2008 .

[25]  D. M. Lynn,et al.  Release of plasmid DNA from intravascular stents coated with ultrathin multilayered polyelectrolyte films. , 2006, Biomacromolecules.

[26]  P. Schaaf,et al.  Comparison of the Structure of Polyelectrolyte Multilayer Films Exhibiting a Linear and an Exponential Growth Regime: An in Situ Atomic Force Microscopy Study , 2002 .

[27]  J. Kankare,et al.  Influence of synthetic polyelectrolytes on the growth and properties of hyaluronan-chitosan multilayers. , 2009, Biomacromolecules.

[28]  J. V. van Horn,et al.  Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. , 2001, The Journal of antimicrobial chemotherapy.

[29]  A. Simpson,et al.  Gentamicin May Have an Adverse Effect on Osteogenesis , 2003, Journal of orthopaedic trauma.

[30]  Michael F. Rubner,et al.  Influence of the Degree of Ionization on Weak Polyelectrolyte Multilayer Assembly , 2005 .

[31]  Y. An,et al.  Animal Models of Osteomyelitis , 2006, The International journal of artificial organs.

[32]  S. Feldman,et al.  Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polycations. , 1982, The Journal of pharmacology and experimental therapeutics.

[33]  P. Hammond,et al.  Polyelectrolyte multilayers for tunable release of antibiotics. , 2008, Biomacromolecules.

[34]  C. Picart.  Polyelectrolyte multilayer films: from physico-chemical properties to the control of cellular processes. , 2008, Current medicinal chemistry.

[35]  B. Lindsey,et al.  Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections. , 2009, Biomaterials.

[36]  Lei Zhai,et al.  Controlled drug release from porous polyelectrolyte multilayers. , 2006, Biomacromolecules.

[37]  D. Fisman,et al.  Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  G. Walenkamp,et al.  Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. , 1998, Acta orthopaedica Scandinavica.

[39]  A. Dinda,et al.  Efficacy of antibiotics-loaded interpenetrating network (IPNs) hydrogel based on poly(acrylic acid) and gelatin for treatment of experimental osteomyelitis: in vivo study. , 2005, Biomaterials.

[40]  L. Dahners,et al.  Better prophylaxis against surgical site infection with local as well as systemic antibiotics. An in vivo study. , 2009, The Journal of bone and joint surgery. American volume.

[41]  Paula T Hammond,et al.  Layer-by-layer platform technology for small-molecule delivery. , 2009, Angewandte Chemie.

[42]  L. Richert,et al.  Polyelectrolyte multilayers functionalized by a synthetic analogue of an anti-inflammatory peptide, alpha-MSH, for coating a tracheal prosthesis. , 2005, Biomaterials.

[43]  G. Prestwich,et al.  Molecular basis for the explanation of the exponential growth of polyelectrolyte multilayers , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Benjamin Thierry,et al.  Bioactive coatings of endovascular stents based on polyelectrolyte multilayers. , 2003, Biomacromolecules.

[45]  D. M. Lynn,et al.  Tunable drug release from hydrolytically degradable layer-by-layer thin films. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[46]  M. Smeltzer,et al.  Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis , 1995, Infection and immunity.

[47]  A. Dierich,et al.  Bone Formation Mediated by Synergy‐Acting Growth Factors Embedded in a Polyelectrolyte Multilayer Film , 2007 .

[48]  Ayako Oyane,et al.  Preparation and assessment of revised simulated body fluids. , 2003, Journal of biomedical materials research. Part A.

[49]  Edgar Erdfelder,et al.  GPOWER: A general power analysis program , 1996 .

[50]  P. Schaaf,et al.  Influence of the polyelectrolyte molecular weight on exponentially growing multilayer films in the linear regime. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[51]  J. Anglen.  Comparison of soap and antibiotic solutions for irrigation of lower-limb open fracture wounds. A prospective, randomized study. , 2005, The Journal of bone and joint surgery. American volume.